Anastrozole — $0 with Membership
Anastrozole has an active canonical formulary match. No-additional-cost pricing is subject to its listed supply, quantity, fill, and fulfillment limits.
Anastrozole Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | $0 with membership |
| Typical Retail | $75.00 |
Free with membership subject to the listed formulary limits.
About Anastrozole
Anastrozole is a prescription medication. Ask your doctor if Anastrozole is right for you.
How to Check Anastrozole Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Anastrozole at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Hormones
What Anastrozole is approved for (FDA label)
Anastrozole tablets are an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer ( 1.1 ) First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer ( 1.2 ) Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy.
Source: Read the full FDA label on DailyMed. Label effective date: August 20, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Anastrozole (FDA label)
The tablets are white to off-white, round, film-coated containing 1 mg of anastrozole. The tablets are debossed with "AN" and "1" on one side and plain surface on the other side. 1 mg tablets ( 3 )
Source: FDA prescribing information (DailyMed). Set ID: 1d1d5818-1594-4f54-90a9-ae9a9afcdc67. SPL document ID: d58de9b1-85aa-4045-a757-776683671017. Label effective date: August 20, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Anastrozole (FDA label)
Serious adverse reactions with anastrozole tablets occurring in less than 1 in 10,000 patients, are: 1) skin reactions such as lesions, ulcers, or blisters; 2) allergic reactions with swelling of the face, lips, tongue, and/or throat.
Source: FDA prescribing information (DailyMed). Set ID: 1d1d5818-1594-4f54-90a9-ae9a9afcdc67. SPL document ID: d58de9b1-85aa-4045-a757-776683671017. Label effective date: August 20, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Anastrozole (FDA label)
Patients with demonstrated hypersensitivity to anastrozole tablets or any excipient ( 4 ) Hypersensitivity Anastrozole tablets are contraindicated in any patient who has shown a hypersensitivity reaction to the drug or to any of the excipients. Observed reactions include anaphylaxis, angioedema, and urticaria [see Adverse Reactions (6.2) ].
Source: FDA prescribing information (DailyMed). Set ID: 1d1d5818-1594-4f54-90a9-ae9a9afcdc67. SPL document ID: d58de9b1-85aa-4045-a757-776683671017. Label effective date: August 20, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Warnings and precautions for Anastrozole (FDA label)
In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events occurred with anastrozole tablet use compared to tamoxifen use. Consider risks and benefits. ( 5.1 , 6.1 ) Decreases in bone mineral density may occur. Consider bone mineral density monitoring. ( 5.2 , 6.1 ) Increases in total cholesterol may occur. Consider cholesterol monitoring. ( 5.3 , 6.1 ) Embryo-Fetal Toxicity: Anastrozole tablets may cause fetal harm. Advise patients of the potential risk to a fetus and to use effective contraception. ( 5.4 , 8.1 ) 5.1 Ischemic Cardiovascular Events In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events was observed with anastrozole tablets in the ATAC trial (17% of patients on anastrozole tablets and 10% of patients on tamoxifen).
Source: FDA prescribing information (DailyMed). Set ID: 1d1d5818-1594-4f54-90a9-ae9a9afcdc67. SPL document ID: d58de9b1-85aa-4045-a757-776683671017. Label effective date: August 20, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Anastrozole (FDA label)
Tamoxifen: Do not use in combination with anastrozole tablets. No additional benefit seen over tamoxifen monotherapy ( 7.1 , 14.1 ) Estrogen-containing products: Combination use may diminish activity of anastrozole tablets ( 7.2 ) 7.1 Tamoxifen Co-administration of anastrozole and tamoxifen in breast cancer patients reduced anastrozole plasma concentration by 27%. However, the co-administration of anastrozole and tamoxifen did not affect the pharmacokinetics of tamoxifen or N-desmethyltamoxifen. At a median follow-up of 33 months, the combination of anastrozole tablets and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation.
Source: FDA prescribing information (DailyMed). Set ID: 1d1d5818-1594-4f54-90a9-ae9a9afcdc67. SPL document ID: d58de9b1-85aa-4045-a757-776683671017. Label effective date: August 20, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.